Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Anbio Biotechnology (NNNN)

8 + Investors. Track Smart Money conviction in NNNN. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +3
Streak
1Q ▲
Buyers last Q
100%

Smart Money Signals — NNNN

Based on 8 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 4Q
For 1 consecutive quarter, more hedge funds added NNNN than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
📊

High ownership — 80% of 1.2Y peak

80% of all-time peak
8 funds currently hold this stock — 80% of the 1.2-year high of 10 funds (reached 2025 Q3). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
🚀

Fast accumulation — +167% more funds vs a year ago

fund count last 5Q
+5 new funds entered over the past year (+167% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks. The peak was reached in just 2 quarters from the low — a sharp move.
🟢

More buyers than sellers — 100% buying

6 buying0 selling
Last quarter: 6 funds were net buyers (3 opened a brand new position + 3 added to an existing one). Only 0 were sellers (0 trimmed + 0 sold completely). A clear majority buying is a strong confirmation signal.
➡️

Steady new buyers — ~3 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 3 → 5 → 0 → 3. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔄

Mostly new holders — 38% entered in last year

0% conviction (2yr+) 62% medium 38% new
Only 0 funds (0%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
⚠️

Saturation — most institutions already know this story

3 → 5 → 0 → 3 new funds/Q
New funds entering each quarter: 3 → 5 → 0 → 3. Far fewer institutions are entering now vs. a year ago. When the pool of potential new buyers shrinks this fast, future price support from institutional inflows weakens significantly.
🌱

Early stage — 100% of holders entered in last year

0% veterans 0% 1-2yr 100% new
Of 8 current holders: 8 (100%) entered in the past year, only 0 (0%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
🏆

Elite ownership — 81% AUM from top-100 funds

81% from top-100 AUM funds
5 of 8 holders are among the 100 largest funds by AUM, controlling 81% of total institutional value in NNNN. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.1
out of 10
Low Exit Risk
Exit risk score 3.1/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — NNNN

In 2026 Q1, 6 hedge funds were net buyers of NNNN (3 opened a new position, 3 added to an existing one), while 0 reduced or exited — a 100% buyer ratio, indicating clear institutional accumulation. 81% of total institutional value in NNNN is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +3 funds (more new holders than closures). Total institutional holders: 8.

Hedge Fund Ownership: NNNN

How many hedge funds hold NNNN — quarterly history vs. share price
Quarterly hedge fund ownership of NNNN vs. share price

Market Analysis: NNNN

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: NNNN

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Anbio Biotechnology (NNNN) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much NNNN has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 36d ago
NNNN
-26.0%
XLV
-30.1%

NNNN outperformed XLV by +4.1% since June 30, 2026.

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

0 top-rated funds 0 high-conviction
Consensus
0.0
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: NNNN
2026 Q2 Stats Unlock in 14 days 8 + Investors

Track Smart Money conviction in NNNN. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 8 5 60.0%
13F Shares 51K 30K 72.8%
Total Value $2M $894K 78.18%
New Positions 3 0 +3
Increased Positions 3 1 +2
Closed Positions 0 5 -5
Reduced Positions 0 2 -2
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: NNNN

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

8 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in NNNN. Verified SEC 13F-HR filings.

QUARTER:
Top 6 NNNN holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 BNP Paribas Financial Markets 0.00% 10,400 $267K
2 Bare Financial Services, Inc 0.00% 15
3 UBS Group AG 0.00% 6,339 $163K
4 Morgan Stanley 0.00% 7,338 $189K
5 Blue Trust, Inc. 0.00% 5
6 Wells Fargo & Company/Mn 0.00% 100 $3K
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Anbio Biotechnology (NNNN)

What does the Smart Money Trend signal show for NNNN?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added NNNN than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for NNNN?

More buyers than sellers — 100% buying: Last quarter: 6 funds were net buyers (3 opened a brand new position + 3 added to an existing one). Only 0 were sellers (0 trimmed + 0 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for NNNN holders?

Elite ownership — 81% AUM from top-100 funds: 5 of 8 holders are among the 100 largest funds by AUM, controlling 81% of total institutional value in NNNN. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held NNNN?

Mostly new holders — 38% entered in last year: Only 0 funds (0%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Anbio Biotechnology (NNNN) following the 2026 Q2 hedge fund 13F filings?

Since the quarter end (June 30, 2026), NNNN has gained -26.0% vs -30.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →